ID   KAT8_RAT                Reviewed;         458 AA.
AC   Q5XI06;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   02-OCT-2024, entry version 152.
DE   RecName: Full=Histone acetyltransferase KAT8;
DE            EC=2.3.1.48 {ECO:0000250|UniProtKB:Q9H7Z6};
DE   AltName: Full=Lysine acetyltransferase 8;
DE   AltName: Full=MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1;
DE            Short=MYST-1;
DE   AltName: Full=Protein acetyltransferase KAT8 {ECO:0000305};
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q9H7Z6};
DE   AltName: Full=Protein propionyltransferase KAT8 {ECO:0000305};
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q9H7Z6};
GN   Name=Kat8; Synonyms=Myst1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND SER-42, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Histone acetyltransferase that catalyzes histone H4
CC       acetylation at 'Lys-5'- and 'Lys-8' (H4K5ac and H4K8ac) or 'Lys-16'
CC       (H4K16ac), depending on the context. Catalytic component of the MSL
CC       histone acetyltransferase complex, a multiprotein complex that mediates
CC       the majority of histone H4 acetylation at 'Lys-16' (H4K16ac), an
CC       epigenetic mark that prevents chromatin compaction (By similarity).
CC       H4K16ac constitutes the only acetylation mark intergenerationally
CC       transmitted and regulates key biological processes, such as oogenesis,
CC       embryonic stem cell pluripotency, hematopoiesis or glucose metabolism
CC       (By similarity). The MSL complex is required for chromosome stability
CC       and genome integrity by maintaining homeostatic levels of H4K16ac (By
CC       similarity). The MSL complex is also involved in gene dosage by
CC       promoting up-regulation of genes expressed by the X chromosome. X up-
CC       regulation is required to compensate for autosomal biallelic
CC       expression. The MSL complex also participates in gene dosage
CC       compensation by promoting expression of Tsix non-coding RNA (By
CC       similarity). As part of the NSL histone acetyltransferase complex,
CC       catalyzes histone H4 acetylation at 'Lys-5'- and 'Lys-8' (H4K5ac and
CC       H4K8ac) at transcription start sites and promotes transcription
CC       initiation. The NSL complex also acts as a regulator of gene expression
CC       in mitochondria: KAT8 associates with mitochondrial DNA and controls
CC       expression of respiratory genes in an acetyltransferase-dependent
CC       mechanism. Also functions as an acetyltransferase for non-histone
CC       targets, such as ALKBH5, COX17, IRF3, KDM1A/LSD1, LMNA, PAX7 or
CC       TP53/p53 (By similarity). Acts as an inhibitor of antiviral immunity by
CC       acetylating IRF3, preventing IRF3 recruitment to promoters. Acts as a
CC       regulator of asymmetric division in muscle stem cells by mediating
CC       acetylation of PAX7 (By similarity). As part of the NSL complex,
CC       acetylates TP53/p53 at 'Lys-120'. Acts as a regulator of epithelial-to-
CC       mesenchymal transition as part of the NSL complex by mediating
CC       acetylation of KDM1A/LSD1 (By similarity). The NSL complex is required
CC       for nuclear architecture maintenance by mediating acetylation of LMNA.
CC       Promotes mitochondrial integrity by catalyzing acetylation of COX17 (By
CC       similarity). In addition to protein acetyltransferase activity, able to
CC       mediate protein propionylation (By similarity).
CC       {ECO:0000250|UniProtKB:Q9D1P2, ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[histone] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[histone]; Xref=Rhea:RHEA:21992, Rhea:RHEA-COMP:9845,
CC         Rhea:RHEA-COMP:11338, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000250|UniProtKB:Q9H7Z6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21993;
CC         Evidence={ECO:0000250|UniProtKB:Q9H7Z6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930;
CC         Evidence={ECO:0000250|UniProtKB:Q9H7Z6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45949;
CC         Evidence={ECO:0000250|UniProtKB:Q9H7Z6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl-[protein] + propanoyl-CoA = CoA + H(+) + N(6)-
CC         propanoyl-L-lysyl-[protein]; Xref=Rhea:RHEA:54020, Rhea:RHEA-
CC         COMP:9752, Rhea:RHEA-COMP:13758, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57392,
CC         ChEBI:CHEBI:138019; Evidence={ECO:0000250|UniProtKB:Q9H7Z6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54021;
CC         Evidence={ECO:0000250|UniProtKB:Q9H7Z6};
CC   -!- ACTIVITY REGULATION: The acetyltransferase activity is inhibited by
CC       anacardic acid derivatives. {ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- SUBUNIT: Component of a multisubunit histone acetyltransferase complex
CC       (MSL) at least composed of the MOF/KAT8, MSL1/hampin, MSL2L1 and
CC       MSL3L1. Component of the NSL complex at least composed of MOF/KAT8,
CC       KANSL1, KANSL2, KANSL3, MCRS1, PHF20, OGT1/OGT, WDR5 and HCFC1.
CC       Component of some MLL1/MLL complex, at least composed of the core
CC       components KMT2A/MLL1, ASH2L, HCFC1, WDR5 and RBBP5, as well as the
CC       facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L,
CC       MAX, MCRS1, MGA, MOF/KAT8, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A,
CC       RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Interacts
CC       with the chromodomain of MORF4L1/MRG15. Interacts with ATM (via its
CC       Tudor-knot domain); possibly regulating the activity of ATM (By
CC       similarity). Interacts with NELFD (By similarity).
CC       {ECO:0000250|UniProtKB:Q9D1P2, ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9H7Z6}.
CC       Chromosome {ECO:0000250|UniProtKB:Q9H7Z6}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q9H7Z6}. Note=Translocated into the nucleus via
CC       its association with importin-alpha-1 (KPNA2). As part of the NSL
CC       complex, associates with the proximal part of promoters and
CC       transcription start sites (By similarity). As part of the MSL complex,
CC       associates with gene bodies (By similarity). Also localizes to
CC       mitochondria; associates with mitochondrial DNA and regulates
CC       mitochondrial gene expression (By similarity).
CC       {ECO:0000250|UniProtKB:Q9D1P2, ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- PTM: Acetylation at Lys-274 facilitates cognate substrate Lys-binding
CC       and acetylation. Although considered as an autoacetylation event,
CC       acetylation at Lys-274 probably takes place via a non-enzymatic process
CC       following acetyl-CoA-binding, which primes KAT8 for cognate protein-
CC       lysine acetylation. Deacetylated by SIRT1.
CC       {ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC083891; AAH83891.1; -; mRNA.
DR   RefSeq; NP_001017378.1; NM_001017378.1.
DR   AlphaFoldDB; Q5XI06; -.
DR   BMRB; Q5XI06; -.
DR   SMR; Q5XI06; -.
DR   STRING; 10116.ENSRNOP00000026527; -.
DR   iPTMnet; Q5XI06; -.
DR   PhosphoSitePlus; Q5XI06; -.
DR   PaxDb; 10116-ENSRNOP00000026527; -.
DR   GeneID; 310194; -.
DR   KEGG; rno:310194; -.
DR   UCSC; RGD:1311512; rat.
DR   AGR; RGD:1311512; -.
DR   CTD; 84148; -.
DR   RGD; 1311512; Kat8.
DR   VEuPathDB; HostDB:ENSRNOG00000019485; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   HOGENOM; CLU_011815_2_1_1; -.
DR   InParanoid; Q5XI06; -.
DR   OrthoDB; 118560at2759; -.
DR   PhylomeDB; Q5XI06; -.
DR   TreeFam; TF317619; -.
DR   Reactome; R-RNO-3214847; HATs acetylate histones.
DR   Reactome; R-RNO-9772755; Formation of WDR5-containing histone-modifying complexes.
DR   PRO; PR:Q5XI06; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000019585; Expressed in testis and 19 other cell types or tissues.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005694; C:chromosome; ISS:UniProtKB.
DR   GO; GO:0000123; C:histone acetyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0000776; C:kinetochore; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0071339; C:MLL1 complex; ISS:UniProtKB.
DR   GO; GO:0072487; C:MSL complex; ISS:UniProtKB.
DR   GO; GO:0044545; C:NSL complex; ISS:UniProtKB.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IBA:GO_Central.
DR   GO; GO:0016363; C:nuclear matrix; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0016407; F:acetyltransferase activity; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0010485; F:histone H4 acetyltransferase activity; ISO:RGD.
DR   GO; GO:0046972; F:histone H4K16 acetyltransferase activity; ISO:RGD.
DR   GO; GO:0043995; F:histone H4K5 acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0043996; F:histone H4K8 acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061733; F:peptide-lysine-N-acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.
DR   GO; GO:0061920; F:protein propionyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:0030099; P:myeloid cell differentiation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:0032480; P:negative regulation of type I interferon production; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; ISO:RGD.
DR   GO; GO:0048477; P:oogenesis; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:1902726; P:positive regulation of skeletal muscle satellite cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060261; P:positive regulation of transcription initiation by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0035166; P:post-embryonic hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; ISO:RGD.
DR   GO; GO:1903108; P:regulation of mitochondrial transcription; ISS:UniProtKB.
DR   GO; GO:0050684; P:regulation of mRNA processing; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045815; P:transcription initiation-coupled chromatin remodeling; ISO:RGD.
DR   CDD; cd18984; CBD_MOF_like; 1.
DR   CDD; cd04301; NAT_SF; 1.
DR   Gene3D; 2.30.30.140; -; 1.
DR   Gene3D; 3.40.630.30; -; 1.
DR   Gene3D; 3.30.60.60; N-acetyl transferase-like; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR050603; MYST_HAT.
DR   InterPro; IPR025995; Tudor-knot.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR040706; Zf-MYST.
DR   PANTHER; PTHR10615; HISTONE ACETYLTRANSFERASE; 1.
DR   PANTHER; PTHR10615:SF82; HISTONE ACETYLTRANSFERASE KAT8; 1.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF11717; Tudor-knot; 1.
DR   Pfam; PF17772; zf-MYST; 1.
DR   SMART; SM00298; CHROMO; 1.
DR   SUPFAM; SSF55729; Acyl-CoA N-acyltransferases (Nat); 1.
DR   SUPFAM; SSF54160; Chromo domain-like; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Acyltransferase; Chromatin regulator; Chromosome;
KW   Metal-binding; Mitochondrion; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Transferase; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   CHAIN           2..458
FT                   /note="Histone acetyltransferase KAT8"
FT                   /id="PRO_0000051568"
FT   DOMAIN          55..110
FT                   /note="Tudor-knot"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          174..447
FT                   /note="MYST-type HAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   ZN_FING         207..232
FT                   /note="C2HC MYST-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   REGION          1..52
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          174..458
FT                   /note="Sufficient for interaction with KANSL1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   MOTIF           140..149
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   ACT_SITE        350
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         210
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         213
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         226
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         230
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         317
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         319
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         325
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         326
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         327
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         329
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         330
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         354
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         363
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         408
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         432
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         42
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         113
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   MOD_RES         274
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
SQ   SEQUENCE   458 AA;  52632 MW;  0D3AFF8A5EDB1459 CRC64;
     MAAQGATAAV AATTSGIVGE GEPGPGENTS VEGPARSPGR VSPPTPARGE PEVTVEIGET
     YLCRRPDSTW HSAEVIQSRV NDQEGREEFY VHYVGFNRRL DEWVDKNRLA LTKTVKDAVQ
     KNSEKYLSEL AEQPERKITR NQKRKHDEIN HVQKTYAEMD PTTAALEKEH EAITKVKYVD
     KIHIGNYEID AWYFSPFPED YGKQPKLWLC EYCLKYMKFE KSYRFHLGQC QWRQPPGKEI
     YRKSNISVYE VDGKDHKIYC QNLCLLAKLF LDHKTLYFDV EPFVFYILTE VDRQGAHIVG
     YFSKEKESPD GNNVACILTL PPYQRRGYGK FLIAFSYELS KLESTVGSPE KPLSDLGKLS
     YRSYWSWVLL EILRDFRGTL SIKDLSQMTS ITQNDIISTL QSLNMVKYWK GQHVICVTPK
     LVEEHLKSAQ YKKPPITVDS VCLKWAPPKH KQVKLSKK
//
